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Background: The relevance of microRNAs (miRNAs) in adipose tissue is increasingly recognized, being intrinsically
linked to different pathways, including obesity-related inflammation. In this study, we aimed to characterize the
changes induced by inflammation on the miRNA pattern of human adipocytes and macrophages. Therefore, an
extensive profile of 754 common miRNAs was assessed in cells (human primary mature adipocytes, and the
macrophage-like cell line THP-1) and in their supernatants (SN) using TaqMan low-density arrays. These profiles were
evaluated at the baseline and after administration of lipopolysaccharide (LPS, 10 ng/ml) and LPS-conditioned
medium from M1 macrophages (MCM, 5%). The miRNAs that experienced the most dramatic changes were studied
in subcutaneous human adipose tissue before and approximately 2 years after bariatric surgery-induced weight loss.
Results: Differentiated adipocytes expressed 169 miRNAs, being 85 detectable in the SN. In M1 macrophages, 183
miRNAs were detected, being 106 also present in the SN. Inflammation led to an increased number of miRNAs
detectable in cells and in their SNs in both adipocytes (+8.3% and +24.7%) and M1 macrophages (+1.4% and +5%,
respectively). Indeed, under inflammatory conditions, adipocytes and M1 macrophages shared the expression of
147 (+9%) miRNAs, and 100 (+41%) common miRNAs were found in their SNs. Twelve of these factors were also
linked to inflammation in whole adipose tissue from obese subjects. Interestingly, miR-221 (2-fold, P = 0.002), miR-222
(2.5-fold, P = 0.04), and miR-155 (5-fold, P = 0.015) were increased in inflamed adipocytes and in their SNs (15-, 6-, and
4-fold, respectively, all P < 0.001). Furthermore, their expressions in human adipose tissue concordantly decreased after
weight loss (−51%, P = 0.003, −49%, P = 0.03, and −54.4%, P = 0.005, respectively).
Conclusions: Inflammation induces a specific miRNA pattern in adipocytes and M1 macrophages, with impact on the
physiopathology of obesity-induced inflammation of adipose tissue. The crosstalk between cells should be investigated
further.
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Obese adipose tissue (AT) is a critical player in chronic
low-grade systemic inflammation, with impact on insulin
resistance through the secretion of hormones, adipocy-
tokines [1], fatty acids [2], and (potentially) microRNAs
[3] that modulate different metabolic pathways in AT it-
self, liver, skeletal muscle, and in the vasculature [4].* Correspondence: fortega@idibgi.org; jmfreal@idibgi.org
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unless otherwise stated.Differentiated adipocytes release a great amount of in-
flammatory cytokines and chemokines (the so-called
adipokines) in response to activated macrophages [5,6].
Weight loss is known to result in reduced macrophage in-
filtration in parallel to decreased expression of pro-
inflammatory genes [7,8]. Many of these factors are able
to maintain sustained subclinical inflammation in obese
AT, and activate other immune cells [9,10].
MicroRNAs (miRNAs) are non-coding RNAs that
modulate gene expression through translational repres-
sion of specific target genes [11]. Many of these smallThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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expressed in obese AT [12]. The close association be-
tween the miRNA expression profile in tissues and
metabolic diseases such as obesity and type 2 diabetes is
being increasingly recognized [13]. Several miRNAs are
involved in adipocyte differentiation [14] and fat cell be-
havior [15]. So far, conditional disruption of Dicer, a key
miRNA processing, may lead to impaired adipogenesis
and fat mass shrinkage [16], reinforcing the relevance of
miRNAs in AT development, inflammation, and metab-
olism. Not only tissue miRNAs play an important role,
since specific circulating miRNA profiles exist in plasma
from obese subjects [17], suggesting that some of these
factors may modulate the systemic metabolic response.
In this study, we aimed to evaluate the main effects of
inflammation on the miRNA profile of differentiated hu-
man adipocytes, the macrophage-like cell line THP-1
(M1), and in their supernatants (SNs). Then, the miRNAs
that experienced the most dramatic changes were evalu-
ated in human subcutaneous AT before and after bariatric
surgery-induced weight loss and the subsequent metabolic
improvement and decreased inflammation.Figure 1 MicroRNA profiles and cluster analysis. MicroRNA profiles in cells
analysis according to the quality of all determinations. Green (controls) for
under normal conditions. Inflamed (Inf) cells are shown in red.Results
Comprehensive miRNA profiling in macrophages and
adipocytes
We measured the expression (cells) and the presence
into the supernatant (SN) of 754 common mature miR-
NAs in differentiated human subcutaneous adipocytes
and the macrophage-like THP-1 cell line (M1) at the
baseline and upon inflammation (Figure 1). Differenti-
ated adipocytes expressed 169 miRNAs (22.3% of the
tested mature miRNAs), and 85 (11.2%) of these factors
were found in the SN (Figure 1 and Additional file 1).
Interestingly, changes regarding miRNA expression pat-
terns and their concentration in SN clearly identified
the inflammatory effects in isolated mature adipocytes
cultured and differentiated in vitro (Figure 1). Indeed,
some miRNAs became undetectable (miR-1274B, miR-
572, and miR-766), while others appeared de novo in
cells (miR-140-5p, miR-222*, miR-376c, miR-411, and
miR-146a) and their SNs (miR-146a, miR-146b, miR-
19a, miR-223*, miR-425, and miR-9*) upon MCM-
induced inflammation (Figure 2). Overall, treatment
with MCM increased the number of miRNAs expressedand their supernatants (SN) after removing Ct values ≥35, and cluster
differentiated adipocytes (MAs) and M1 macrophages (M1) cultured
Figure 2 Major variations in miRNA profiles. Major variations in miRNA detection in cells and supernatants (SN) upon inflammation (Inf).
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tantly with increased IL-6 (79-fold change, P = 0.004) and
TNFα (14-fold change, P < 0.0001) gene expression
(Table 1).
On the other hand, expression of 183 miRNAs (24%)
and the presence in the SN of 106 (14%) were detected
in M1 macrophages. Inflammatory stimuli with LPS in-
creased the number of miRNAs expressed (+1.4% with
respect to basal) and found in the SN (+5%) of differen-
tiated M1 macrophages. Among them, miR-628-3p and
RNU44 (detectable in SN at the basal level but not after
treatment with LPS) and miR-1243, miR-193b*, and
miR-597 (detectable in SN upon inflammation, Figure 2)
changed their detection levels after stimulation. How-
ever, these qualitative changes did not reach significance
enough to discriminate activated cells from controls
(Figure 1). Indeed, the inflammatory reaction of LPS-
stimulated M1 macrophages, as inferred from changes
in the expression of well-recognized pro-inflammatory
genes such as IL-6 and TNFα (17.7-fold change, P =
0.002, and 4.9-fold change, P = 0.001, respectively), did
not show such great impact, when compared to the
changes accounted in mature adipocytes upon inflam-
mation (Table 1). The lack of major differences in stimu-
lated M1 macrophages was more probably due to the
transient basal inflammatory state that the induction of
the mature type 1 macrophage-like state M1 (by treating
THP-1 cells with phorbol 12-myristate 13-acetate) pro-
motes per se. Nonetheless, under basal conditions adi-
pocytes and M1 macrophages shared expression of 135,
and 71 common mature miRNAs were found in SNs
from both cell lines. Upon inflammatory stimuli, dif-
ferentiated adipocytes and isolated M1 macrophagesexpressed 147 (+9%) common mature miRNA species,
and 100 (+41%) of these factors were found in the SN
(Additional file 2: Table S1).
Quantitative changes upon inflammation
When comparing normalized values of quantifiable miR-
NAs (Cts <35 in all replicates) either in cells or the SNs
of M1 macrophages and isolated adipocytes following or
not treatment (inflammation vs. control), significant
changes in 18 mature miRNAs were identified in ma-
ture adipocytes and 24 in M1 macrophages (Table 1).
Among them, increased expression of miR-221 (2-fold,
P = 0.002), miR-222 (2.5-fold, P = 0.04), and miR-155
(5-fold, P = 0.015, Figure 3) was found in inflamed adi-
pocytes, as well as in the SN (15-, 6-, and 4-fold
changes, respectively, all with P values under 0.001,
Figure 3), when compared to control. Other significant
changes in isolated adipocytes included increased expres-
sion of miR-132, miR-17, miR-31, miR-93, and miR-345
and decreased miR-422a expression. In the SN, increased
concentrations of miR-19b, miR-92a, miR-342-3p, miR-
223, and miR-20a and decreased miR-199a-3p, miR-214,
miR-193b, and miR-152 were also identified (Table 1).
On the other hand, increased expressions of miR-155
(2.5-fold, P = 0.001) but decreased miR-221 (0.49-fold,
P = 0.034) were found in LPS-stimulated M1 macro-
phages (Table 1). Although no significant variations
were identified in miR-222, modulation of miR-19a (0.5-
fold, P = 0.032, and 2-fold, P = 0.034) and decreased miR-
145 in both cells and SNs (0.2-fold, P = 0.005, and 0.14-fold,
P = 0.032) were shown in M1 macrophages reacting to LPS
(Table 2). Other relevant changes in macrophages included
increased miR-146a (5-fold change, P < 0.0001), and the
Table 1 Significant modulation of miRNAs expressed and/
or secreted (supernatant) by M1 macrophages upon
lipopolysaccharide (LPS, 10 ng/ml) stimuli and mature
adipocytes treated or not with macrophages
LPS-conditioned medium (MCM, 5%)
Expression Supernatant
Ratio P value Ratio P value
Inflamed (5% MCM)/control mature adipocytes (MAs)
IL-6 mRNA 78.56 0.004
TNFα mRNA 14 <0.0001
miR-155 5.01 0.015 4.03 <0.0001
miR-132 3.17 0.011
miR-222 2.51 0.044 6.07 0.001
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Results assessed were compared by Student t-test. Italics for significant results.
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which were superseded by increased presence in the SN of
another set of nine different miRNAs (Table 1).
In vivo validation
Noteworthy, qRT-PCR analyses in AT from morbid
obese subjects following approximately 2 years of weight
loss identified significant changes in 12 of 18 miRNAs
(67%) shortlisted by analyses in vitro (Table 2). Cur-
rently, it is well recognized that, when compared with
conventional strategies, the physiological impact of bar-
iatric surgery is of particular interest, with regard to
short-term weight loss and improvement of inflamma-
tion [18]. Indeed, concomitantly with weight loss and
improved AT inflammation (Additional file 2: Table S2),
current data pointed decreased AT expression of miR-
NAs which detection inside isolated cells (for example,
miR-146b, miR-376c, miR-411) and/or in the SN (miR-
221, miR-222, miR-155, miR-223, miR-19a/b) rose in differ-
entiated adipocytes upon inflammatory stimuli (Table 2).
On the other hand, some miRNAs highlighted by either
differential expression or concentrations in the SN of
inflamed M1 macrophages, such as miR-146a, miR-155,
and miR-19a, also showed decreased expression in hu-
man obese AT after weight loss (Table 2).
Discussion
Current results indicate that inflammation alters miRNA
profiles in adipocytes and macrophages. Adipose tissue
(AT) exhibits inflammation as tissue mass expands in
obesity, involving macrophage infiltration and the in-
flammatory response of adipocytes [8]. Analyses of AT
before and after weight loss have revealed a reduction
in macrophage number and decreased expression of
pro-inflammatory genes [7]. There is preliminary informa-
tion about the potential involvement of post-transcriptional
regulatory elements such as microRNAs (miRNAs) in this
context [19]. Indeed, secreted miRNAs may target
Figure 3 Bars representing the mean ± standard error for miR-221, miR-222, and miR-155. Bars representing the mean ± standard error for
miR-221, miR-222, and miR-155 in differentiated adipocytes and their SN at the baseline and upon MCM-conditioned inflammation (striped
bars) and in human AT before (striped bars)-after massive weight loss. The geometric average of all analyzed miRNAs was used as normalizing factor in
cells and the SNs, respectively. RNU6b was used as reference miRNA in human adipose tissue. Bottom tables provide normalized values as mean ±
standard deviation (minimum-maximum). *P < 0.05, **P < 0.01, and #P < 0.0001 (Student’s or paired t-test) for comparisons treatment vs. control, pre- vs.
post-weight loss.
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them [3,19,20].
The most recent studies have revealed that plasma
membrane-derived vesicles, namely exosomes and micro-
vesicles, can transfer miRNAs from donor to recipient
cells [21]. These extracellular vesicles are not simply ‘gar-
bage bags’ or a route for exclusion of surplus molecules
but active effectors in mediating adaptive responses in tar-
geting cells [22]. Others have demonstrated that more
extracellular vesicles containing miRNAs are released in
ex vivo adipose tissue cultures of mice feeding a high-fat
diet and of leptin-deficient obese mice when compared to
control mice [23]. These exosomes released to the super-
natant are predicted to have both local and systemic ef-
fects, being taken up by resident macrophages and leading
to their activation in adipose tissue. Because of this activa-
tion, more macrophages may be recruited into AT to
further increase the inflammatory response, with more
miRNAs released from inflamed AT [23]. Also, HDL
transports large amounts of endogenous miRNAs, being
suggested as the possible mechanism whereby some of
the biological effects of HDL could be explained [3].The molecular mechanisms of RNA-based cell-to-cell
communication and the exact process of how extracel-
lular vesicles and HDL are loaded with miRNAs have
not been characterized yet and, thus, the pathways in-
volved remain largely unknown. However, since signifi-
cant differences regarding miRNAs contained in AT
[14] and the circulation [17] of obese patients exist, ex-
pression and secretion by inflamed adipocytes and acti-
vated M1 macrophages might be attractive candidates
in this field.
Inflammation alters miRNA profiles in adipocytes and
macrophages
Upon inflammation, an increased number of miRNAs
were detectable in stimulated adipocytes and M1 macro-
phages, when compared to the basal conditions. This in-
crease was more noticeable when studying the miRNAs
that are found in the supernatant (SN) of adipocytes.
Identification of miR-146a and miR-146b in adipocytes
upon inflammation (but not under basal conditions), for
example, was consistent when analyzing both cells and
SNs, decreasing in human AT after weight loss. This
Table 2 Testing of inflammation-induced miRNA candidates identified in vitro in human subcutaneous adipose tissue
(AT) samples
Inflamed (5% MCM)/control adipocytes Inflamed (10 ng/ml LPS)/control macrophages Obese AT/post-weight loss
Expression Supernatant Expression Supernatant Human AT (n = 9)
Ratio P value Ratio P value Ratio P value Ratio P value % change P value
miR-146b Only detectable in the SN of inflamed MAs −88 <0.0001
miR-146a 4.96 <0.0001 −69.6 0.002
miR-376c Only detectable in inflamed MAs −78 0.002
miR-221 1.98 0.027 15.43 0.002 0.49 0.034 −51.3 0.003
miR-223 4.87 0.001 −74.3 0.004
miR-411 Only detectable in inflamed MAs −62.2 0.004
miR-155 5.01 0.015 4.03 <0.0001 2.48 0.001 −54.4 0.005
miR-19b 19.76 <0.0001 0.61 0.009 −72.7 0.006
miR-19a Only detectable in the SN of inflamed MAs 0.49 0.032 2.02 0.034 −73.4 0.008
RNU48 0.22 0.015 −45 0.009
miR-222 2.51 0.044 6.07 0.001 −48.9 0.028
miR-193b 0.37 0.014 −44.8 0.039
miR-766 Undetectable in inflamed MAs 182 0.084
let-7a 0.12 0.014 6.1 0.276
miR-145 0.19 0.005 0.14 0.032 −26.9 0.228
miR-92a 7.73 0.002 1.75 0.007 −21.3 0.327
miR-572 Undetectable in inflamed MAs −7.6 0.413
miR-378 4.95 0.014 −41 0.78
Results from nine morbid obese participants before and after surgery-induced weight loss (post-weight loss, see Additional file 2: Table S2 for additional details).
Results assessed were compared by paired t-test. ‘Detectable’ refers to <35 Cts, while ‘undetectable’ indicates ≥35 Cts in all biological replicates (n = 3), as
explained above. Italics for significant results.
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mass expands in mice models of obesity [24]. On the
other hand, the expression of ‘miRNokines’ such as miR-
146b, miR-376c, miR-411, and miR-19a by inflamed adi-
pocytes/obese AT may hint into functional activities be-
yond adiposity, such as recruitment of immune cells
[25], or modulation of insulin-secreting cells [26]. For in-
stance, miR-19b directly regulates the formation of ‘foam
cells’ derived from macrophages [27] and was measurable
here in the SN of LPS-activated M1 macrophages (but not
in controls). This may suggest mechanisms by which cells
release a particular set of miRNAs to the SN and miRNAs
which are more likely to be kept inside cells. Further
investigations are needed in order to determine these
mechanisms.
In differentiated adipocytes, miR-221, miR-222, and
miR-155 were detectable and measurable in both cells
and SNs, being their values significantly increased upon
inflammation. These three miRNA candidates were also
associated with obesity and weight loss, when analyzed
in AT samples. Indeed, this increased expression in
obese AT has been reported previously [24,14], as well
as their association with AT oxidative stress, apoptosis,
and inflammatory events [28]. In agreement with currentresults, macrophages in atherosclerotic lesions exhibit
increased expression of miR-155, which also responds to
inflammatory cues [29]. On the other hand, TNFα in-
duced the expression of both miR-221 and miR-222,
which were also found to be downregulated during
adipogenesis and upregulated in obese mice [30]. The
concordant and sustained changes in the expression
of these three miRNAs seem to be connected with inflam-
matory nodes in obese AT, suggesting their participation
in regulatory networks underlying adipogenesis and AT
dysfunction. In this respect, three major target genes
[c-Cbl protein, phosphoinositide-3-kinase regulatory
subunit 1 (PI3KR1), and the suppressor of cytokine sig-
naling 1 (SOCS1)] for the in silico intersection between
two of the more relevant miRNAs in the context of in-
flammation affecting fat cells, the miR-155 and miR-
221 (Additional file 1: Table S3), are involved in insulin
pathway (Additional file 3: Figure S2) and, thus, may
participate of insulin resistance and type 2 diabetes
(Additional file 3: Figure S3) [31]. The PIK3R1 gene,
encoding the p85 regulatory subunit of phosphatidylinositol
3-kinase (PI3K), couples insulin and leptin signaling
pathways, playing a critical role in mediating AT insu-
lin sensitivity, and the initiation and propagation of the
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Casitas b-lineage lymphoma (CBL) plays an important
role in AT hyperplasia and insulin action, independ-
ently of the PI3K/Akt pathway [33]. The ability of insu-
lin to stimulate glucose uptake relies on a complex
signaling cascade that leads to the translocation of glu-
cose receptors to the membrane. Thus, the modulation
of expression and secretion of these miRNAs in AT,
particularly in adipocytes, may contribute to the im-
provement of insulin sensitivity following massive fat
mass loss and decreased inflammation. Understanding
the miRNA profiles associated with different pathways
for macrophage activation could also provide a new
spectrum of biomarkers for identification and a poten-
tial therapeutic approach to mitigate entry into tissues
and the onset of inflammatory diseases.
miRNA profiles in macrophages and adipocytes and their SNs
Type 1 macrophage-like human monocytes and human
subcutaneous differentiated adipocytes share expression
of several miRNAs, being this expression enhanced in
the former. The data agrees with accumulating evidence
that adipocytes and immune cells show common fea-
tures, with expression of genes previously considered to
be specific of one lineage [34], and the concept that pro-
inflammatory components are not only secreted by the
stromal-vascular cell fraction but also by differentiated
adipocytes [35]. Notably, when comparing inflamed adi-
pocytes and M1 macrophages, the number of miRNAs
that were only detectable in adipocytes or in macro-
phages decreased, especially when analyzing their SNs.
Thus, the similitude between mature adipocytes and
macrophages [36] becomes clearer through concomitant
changes in miRNA expression pattern and the miRNAs
found in the SN when inflammation appears.
Conclusions
Current results highlight the existence of cell-dependent
miRNA profiles inside and in the SN of isolated adipo-
cytes and M1 macrophages. Obesity-related inflamma-
tion increases the production of miRNAs and alters the
expression pattern in both cells and SNs. Understanding
miRNA profiles associated with different pathways of ad-
ipocytes and macrophages activation may provide a new
spectrum of biomarkers and therapeutic approaches to
mitigate macrophage infiltration in obese AT and the onset
of obesity-associated inflammation. Variations regarding
miR-221/222 and miR-155, for example, may participate
in the crosstalk between obesity-related inflammation,
insulin resistance, and other obesity-associated morbid-
ities. This work paves the way for future clinical and cel-
lular studies aimed at determining the impact of these
molecular adaptations on the development of obesity-
related inflammation and such deleterious effects.Methods
Cell culture
The human monocyte cell line THP-1 (ATCC®) was cul-
tured in RPMI 1640 medium containing 10% fetal bovine
serum, 5 mM glucose, 2 mM L-glutamine, 50 mg/ml gen-
tamicin, and 20 mM HEPES at 37°C in a humidified 5%
CO2 and 95°C air atmosphere. The mature type 1
macrophage-like state (M1) was induced by treating
THP-1 cells with 0.162 mM of phorbol 12-myristate
13-acetate (PMA) for 24 h. Differentiated, plastic-adherent
cells were washed with cold Dulbecco’s phosphate-buffered
saline (Sigma Chemical Co., St. Louis, MO, USA) and incu-
bated with fresh medium without PMA. Differentiated M1
macrophages were treated with fresh medium and fresh
medium containing 10 ng/ml of lipopolysaccharides (LPS,
Sigma Chemical Co.) for an additional 24-h period (three
biological replicates per treatment), as previously described
[5]. Then, the medium was collected and centrifuged at
400 · g for 5 min, diluted with adipocyte medium (Zen-Bio,
Inc., Research Triangle Park, NC, USA), and used as
macrophage LPS-conditioned media (MCM, 5%) to induce
inflammation in differentiated human adipocytes (MAs).
Human subcutaneous preadipocytes from a non-diabetic
Caucasian male with body mass index (BMI) <30 and
age <40 (Zen-Bio, Inc.) were cultured with the Prea-
dipocytes Medium (PM, Zen-Bio, Inc.) in a humidified
37°C incubator with 5% CO2 and 95°C air atmosphere.
Twenty-four hours after plating, cells were checked for
confluence and differentiated using the commercially
available Differentiation Medium (DM, Zen-Bio, Inc.)
following manufacturer’s instructions. Two weeks after
initializing differentiation, cells appeared rounded with
large lipid droplets in the cytoplasm. Cells were consi-
dered mature adipocytes and incubated with fresh adi-
pocytes media (control) or fresh media containing 5%
MCM, to mimic the inflammatory milieu of obese AT.
After 24 h of treatment, the supernatants were centri-
fuged at 400 · g for 5 min, and both pellets and supernatants
were removed and stored at −80°C for future analysis. Three
biological replicates per treatment were performed and
analyzed (Additional file 3: Figure S1 - Workflow diagram).
Subject recruitment
Expression and validation of the miRNAs shortlisted
in vitro was assessed in subcutaneous abdominal adipose
tissue (AT) from nine morbidly obese women before and
after approximately 2 years of surgery-induced weight
loss (BMI = 43.4 ± 5 kg/m2, age = 48 ± 10 years [mean ±
SD], Additional file 2: Table S2). These volunteers were
recruited at the Department of Diabetes, Endocrinology
and Nutrition and the Department of Surgery of the
Hospital ‘Dr Josep Trueta’ of Girona (Girona, Spain). All
subjects provided written informed consent before enter-
ing the study, were of Caucasian origin, and reported
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before entering the study. No systemic diseases other
than obesity were reported. All participants were free of
any infections in the previous month before entering the
study. Liver and thyroid dysfunction were specifically ex-
cluded by biochemical work-up. Other exclusion criteria
included the following: 1) clinically significant hepatic,
neurological, or other major systemic disease, including
malignancy, 2) history of drug or alcohol abuse or serum
transaminase activity more than twice the upper limit of
normal, 3) an elevated serum creatinine concentration,
4) acute major cardiovascular event in the previous 6
months, 5) acute illnesses and current evidence of high-
grade chronic inflammatory or infective diseases, and 6)
mental illness rendering the subjects unable to understand
the nature, scope, and possible consequences of this study.
The study protocol was approved by the Ethics Commit-
tee and the Committee for Clinical investigation (CEIC) of
the Hospital ‘Dr. Josep Trueta’ of Girona, so we certify
that all applicable institutional regulations concerning the
ethical use of information and samples from human sub-
jects were followed during this research.
RNA extraction
Total RNA, including small RNA species such as miR-
NAs, was extracted and purified from AT and cells
(macrophages and adipocytes) using miRNeasy® Mini
Kit (QIAGEN, Gaithersburg, MD, USA). AT samples
(approximately 150 μg) and cells were homogenized in
0.6 mL of QIAzol® Lysis Reagent (QIAGEN), a mono-
phasic solution of phenol and guanidine thiocyanate
which facilitates sample disaggregation and inhibits
RNAses. After addition of chloroform (0.4 volumes),
the homogenate is separated into aqueous and organic
phases by centrifugation (15 min at 12,000 · g and 4°C).
Then, the upper aqueous RNA-rich phase was isolated
and ethanol absolute (1.5 volumes) was added to pro-
vide appropriate binding conditions for all RNA mole-
cules, including miRNAs. The sample was applied to a
silica-membrane RNeasy spin columns, where RNA
binds to the membrane while phenols and other com-
pounds are washed away. High-quality RNA was finally
eluted in 30 μL of RNAse-free water. Final RNA con-
centrations were assessed with a Nanodrop ND-1000
Spectrophotometer (Thermo Fischer Scientific, Wilmington,
DE, USA). The integrity was checked with the Nano lab-on-
a-chip assay for total eukaryotic RNA using Bioanalyzer
2100 (Agilent Technologies, Palo Alto, CA, USA).
miRNA profiles were assessed in cell supernatant (SN)
following standard procedures previously optimized for
plasma [17]. First, floating cells were removed from the
media by an additional centrifugation of 2,000 · g for 5
min at 4°C using a laboratory centrifuge (Beckman J-6M
Induction Drive Centrifuge, Palo Alto, CA, USA). RNAextraction from cell media was performed using the
mirVana PARIS Isolation Kit (Applied Biosystems,
Darmstadt, Germany), as previously described [17].Retrotranscription to cDNA and pre-amplification
A 2,000 ng of total RNA from AT and cell debris and a
fixed volume of 3 μL of RNA solution from the 40-μL
eluate of RNA isolation performed in SN were used as
input into the reverse transcription (RT), using the TaqMan
miRNA Reverse Transcription Kit and TaqMan miRNA
Multiplex RT Assays, which are required to run the
TaqMan Array microRNA Cards (Applied Biosystems).
Pre-amplification was performed in RNA samples from
SN using TaqMan PreAmp Master Mix and Megaplex™
PreAmp Primers (human pool set A and B), which pro-
vided an optional amplification step prior to real-time
analysis when the RNA sample is limiting. This step is
mandatory to provide reliable results in the SN, as well
as in plasma [17].miRNA profiling using TLDAs
TaqMan low-density arrays (TLDAs) for miRNAs, cover-
ing a total amount of 754 miRNA species, were applied
to three biological replicates. Real-time (RT)-PCR was
carried out on an Applied Biosystems 7900HT thermo-
cycler. Data were analyzed with SDS Relative Quantifica-
tion Software version 2.2.2 (Applied Biosystems), with
an assigned minimum threshold above the baseline of all
assays showing measurable amplifications above back-
ground and threshold thermal cycles (Cts) below 35.
The geometric average of all analyzed miRNAs was used
as normalizing factor in cells and the SN. Normalized
relative log10 ratios were used for posterior statistical
tests, as previously described [37].Analysis of individual miRNAs using TaqMan hydrolysis
probes
Commercially available TaqMan hydrolysis probes (Ap-
plied Biosystems) were used to assess the expression of
individual miRNAs in human AT. After RNA extraction
and retrotranscription of 2,000 ng of RNA, the product
was diluted (1:100) previous being combined (5 μL) with
0.25 μL of TaqMan miRNA hydrolysis probes (20×) and
4.75 μL of the LightCycler 480 Probes master mix (2×)
(Roche Diagnostics, Barcelona, Spain) to a final volume
of 10 μL. Gene expression was assessed by real-time
PCR using the LightCycler® 480 Real-Time PCR System
(Roche Diagnostics, Barcelona, Spain) and TaqMan
technology suitable for relative gene expression quantifica-
tion following manufacturer’s protocol. RNU6b (NCBI Ac-
cession ID#: NR_002752, assay ID#: 4395470) was used as
reference miRNA (or endogenous control) in human AT.
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Three micrograms of total RNA were reverse transcribed
to cDNA using High-Capacity cDNA® Archive Kit (Applied
Biosystems, Darmstadt, Germany) according to manu-
facturers’ protocols. Commercially available and pre-
validated TaqMan® primer/probe sets were used for gene
expression determinations (Applied Biosystems). Ex-
pression was assessed by real-time PCR using the Light-
Cycler® 480 Real-Time PCR System (Roche Diagnostics,
Barcelona, Spain) and TaqMan® technology suitable for
relative gene expression quantification. The reaction was
performed following manufacturers’ instructions in a final
volume of 7 μl. The cycle program consisted of an initial
denaturing of 10 min at 95°C then 45 cycles of 15-s dena-
turizing phase at 92°C and 1-min annealing and extension
phase at 60°C. Then, the crossing point (Cp) values were
assessed for each amplification curve by the second de-
rivative maximum method. ΔCp value was first calculated
by subtracting the Cp value for corresponding endogenous
controls in each sample from the Cp value for each
sample and target gene. Fold changes compared with the
endogenous control were then determined by calculating
2−ΔCp, so gene expression results are expressed as expres-
sion ratio relative to preselected and validated endogenous
control. The commercially available and pre-validated
TaqMan® primer/probe sets used here for gene expression
were as follows: interleukin 6 (IL-6, Hs00985639_m1),
tumor necrosis factor (TNFα, Hs01113624_g1), and leptin
(LEP, Hs00174877_m1). Peptidyl-prolyl cis-trans isomer-
ase A (PPIA, Hs99999904_m1, also known as cyclophilin
A) expressions were assessed as endogenous control in
each reaction and sample. Replicates and positive and
negative controls were included.
Statistical methods
Tables were constructed for qualitative evaluation of the
number and identity of miRNAs shared among all sam-
ples and cells. Tables for each group of treatments indi-
cate the number of observed raw RT-PCR values below
35 Cts in three biological replicates. The detectability of
miRNA in cells or SN under different conditions was
established on less than 35 Cts for all replicates (n = 3).
Regarding quantitative differences, normal distribution
and homogeneity of variances were evaluated using
Levene’s test before conducting statistical analysis. Vari-
ables were given in a base log10 transformation and ana-
lyzed on that log10 scale when necessary. Student’s or
paired t-tests were performed to study differences be-
tween groups of samples. Data analyses were performed
with the SPSS statistical software (SPSS v13.0, IBM,
Chicago, IL, USA) and the R Statistical Software (http://
www.r-project.org/). Potential miRNA target genes and
pathways were identified using DIANA-mirPath [31]
and TargetScan 6.0 [38].Additional files
Additional file 1: Supplemental information - raw data.
Additional file 2: Table S1. Most significant differences regarding
miRNA availability in macrophages (M1) and adipocytes (MAs) and into
supernatants (SNs) at the basal level and upon inflammation (Inf).
Table S2. Anthropometric and biochemical data and expression results
in subcutaneous adipose tissue samples from nine participants recruited
for validation in vivo before (baseline) and after (post-weight loss)
bariatric surgery. Table S3. Intersection of in silico identified target
genes of miR-155 and miR-221. †Their involvement in insulin signaling is
represented in Additional file 3: Figure S2 and S3.
Additional file 3: Figure S1. Workflow diagram. Figure S2. Insulin
signaling pathway showing the involvement of CBL, SOCS1, and PIK3R1
(yellow boxes). Their post-transcriptional regulation may be accomplished
by both miR-221 and miR-155. Figure S3. SOCS1 and PIK3R1 (yellow
boxes) in the context of type II diabetes and impaired glucose intake.
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